Spermosens AB (SPERM.ST)
Spermosens AB operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Lund, SN, SE. The stock last traded at $0.01, up 0.00% on the session, giving a market capitalisation of $27.3M. Its beta of 0.13 implies it has historically moved less than the broad market.
Spermosens AB (publ) provides diagnostic health care products and services in Sweden. The company offers devices for male infertility for fertility diagnostics and treatments for the IVF market. It develops JUNO-Checked, a device that measures the binding between sperm and egg cell to enable individualized choice of fertility treatment based on measured binding. Spermosens AB (publ) was incorporated in 2018 and is headquartered in Lund, Sweden.
Spermosens AB is most often compared with the following Healthcare names: